SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044063
Filing Date
2024-11-07
Accepted
2024-11-07 17:22:01
Documents
45
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 865639
2 ex10-1.htm EX-10.1 201503
3 ex31-1.htm EX-31.1 17899
4 ex31-2.htm EX-31.2 18275
5 ex32-1.htm EX-32.1 7232
6 ex32-2.htm EX-32.2 7175
  Complete submission text file 0001493152-24-044063.txt   4527680

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE thar-20240930.xsd EX-101.SCH 26068
8 XBRL CALCULATION FILE thar-20240930_cal.xml EX-101.CAL 26668
9 XBRL DEFINITION FILE thar-20240930_def.xml EX-101.DEF 115761
10 XBRL LABEL FILE thar-20240930_lab.xml EX-101.LAB 299548
11 XBRL PRESENTATION FILE thar-20240930_pre.xml EX-101.PRE 230365
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 599365
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 241437169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)